Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extinction training in tinnitus with pregabalin
2006-002010-35Phase 2Active
- Sponsor
- Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pregabalin in tinnitus (2 arms), sponsored by Prof. Herta Flor, Head of the Institute of Clinical and Cognitive Neuroscience. Primary endpoints: Reduction in tinnitus parameters/interference during multiple-baseline design and Psychological and psychophysical assessments. Started Aug 2006; status: active.
02
Drugs
pregabalin
03
Conditions
tinnitus
Beyond the preview
Go deeper on 2006-002010-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002010-35.